Here's How Much You Would Have Made Owning Apellis Pharmaceuticals Stock In The Last 5 Years
Portfolio Pulse from Benzinga Insights
Apellis Pharmaceuticals (NASDAQ:APLS) has significantly outperformed the market in the last 5 years, with an annualized return of 36.05%, growing a $100 investment to $451.80. The company now has a market capitalization of $8.01 billion.

February 22, 2024 | 9:30 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Apellis Pharmaceuticals has shown remarkable performance over the past 5 years, with an annualized return of 36.05%, significantly outperforming the market.
The significant outperformance of Apellis Pharmaceuticals over the past 5 years, as indicated by its 36.05% annualized return and the growth of a $100 investment to $451.80, suggests a strong positive sentiment and robust financial health. This historical performance, coupled with a substantial market capitalization of $8.01 billion, is likely to instill confidence in investors, potentially leading to a short-term positive impact on the stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100